Nilotinib can override dasatinib resistance in chronic myeloid leukemia patients with secondary resistance to imatinib first-line therapy.

Article Details

Citation Copy to clipboard

Breccia M, Cannella L, Nanni M, Stefanizzi C, Alimena G

Nilotinib can override dasatinib resistance in chronic myeloid leukemia patients with secondary resistance to imatinib first-line therapy.

Acta Haematol. 2007;118(3):162-4. Epub 2007 Sep 20.

PubMed ID

17890849 [ View in PubMed

]

Abstract

Not Available